Positive myocardial imaging was undertaken on 120 unselected patients admitted to a coronary care unit with clinical suspicion of acute myocardial infarction. Multipurpose mobile gamma-cameras were used for serial imaging after administration of 9 9mtechnetium-labelled imidodiphosphonate, a low-cost radiopharmaceutical that is 97% specific for myocardial necrosis, with myocardial uptake and blood clearance most suitable for myocardial imaging. The sensitivity of detection was 94% for patients whose infarction was unequivocal on the ECG; when the presence of raised enzyme concentrations was also used as a criterion for myocardial necrosis, the overali sensitivity for all 120 patients remained 94%. In 73 patients (61%), whose
Introduction
Radioisotope imaging of acute myocardial infarction1 may be achieved by using either radiopharmaceuticals which perfuse normal myocardium and show infarction as a negative shadow (negative imaging)2 3 or agents that are selectively concentrated in necrotic areas (positive imaging).3 6 Although negative imaging yields results during the first few hours after infarction, it is less satisfactory since it cannot differentiate between old and new myocardial damage, cannot be used for serial imaging or sizing of infarction against time or treatment, is highly expensive, and has inappropriate energy levels and myocardial uptake for optimal gamma-camera imaging. The low cost of radiopharmaceuticals for positive imaging (usually 9smtechnetium-labelled phosphates) justifies their continued use as a routine aid to diagnosis in suspected acute myocardial infarction.
Most reports have described the use of 99mtechnetium-labelled pyrophosphate (99mTc-PyP), and, although this R DONALDSON, technique achieves satisfactory imaging, it has not gained widespread acceptance. It has a relatively low specificity, giving many false-positive results,7-'0 and a fairly high incidence of false-negative scans-that is, a doubtful sensitivity-which has tended to limit its application."' To estimate sensitivity and specificity, however, imaging results must be compared with ECG and enzyme evidence.7 8 As these latter techniques are themselves less than 100"( sensitive and specific, their value as a standard by which to judge a new technique is unsatisfactory and may give an inaccurate assessment. Any assessment of myocardial infarction imaging should therefore take account of the limits of conventional enyzme and ECG methods.
Radioisotope imaging, if of sufficient sensitivity and specificity, would be of value in diagnosing myocardial infarction, as uninterpretable or unhelpful ECGs are common and enzyme data may yield borderline or, later in the evolution of the infarction, normal results. Animal and clinical data have shown that 9 9mtechnetium-labelled imidodiphosphonate (99mTc-IDP) has a considerably higher specificity for necrotic myocardium and is more rapidly cleared from blood than 99mTc-PyP.l2 13 We therefore carried out a study to establish whether information derived from acute positive myocardial infarction imaging with 99mTc-IDP was sufficiently reliable and added sufficient useful additional information to other routine diagnostic tools to justify its routine use in patients admitted to acute coronary care units.
Patients and methods
One hundred and twenty consecutive and unselected patients who were admitted to the coronary care unit entered the study. All were suspected of having, and were treated for, acute myocardial infarction on clinical criteria. Eighty-two patients gave histories of typical cardiac pain unrelieved by rest infarction,'4 and a subendocardial infarction was diagnosed according to the criteria of Friedberg", and also, for this study, in the presence of T-wave inversion without ST-segment changes. ECGs were also analysed for pre-existing myocardial damage, including previous myocardial infarction; ventricular hypertrophy; and disorders of electrical activation, which included bundle-branch block, preexcitation, and ventricular pacing.
Results
Transmural infarctiont-Forty-seven patients had ECG evidence of transmural infarction, and of these, 44 had positive 99-Tc-IDP scans. All had raised serum CK concentrations. Three patients with negative scans had inferior myocardial infarctions.
Subendocardial infarction-Twenty patients were judged to have subendocardial infarction on the basis of ECG criteria. Fourteen had positive and six negative scans. Thus, on the basis of ECG criteria alone, the sensitivity of detection was 700,. The Summary and conclusions A patient with Graves's disease with acute progressive exophthalmos and pretibial myxoedema was treated twice with plasmapheresis. Two weeks after the first treatment the symptoms recurred, but 20 weeks after the second treatment the exophthalmos was much improved and the pretibial myxoedema had disappeared. Analysis of sequential serum IgG concentrations and the thyroid-stimulating immunoglobulin index suggested that the two conditions were caused by specific IgGs.
The results suggest that plasmapheresis has a useful place in the treatment of acute and rapidly progressive ophthalmopathy and pretibial myxoedema in patients with Graves's disease.
Introduction
Graves's disease is characterised by abnormal immunoglobulin G's (IgG) in the plasma. Some of these displace thyrotrophin (TSH) bound to the thyroid follicular cell membranel-5 and are known as thyroid-stimulating immunoglobulins (TSI). Others have biological effects on orbital tissues,6-1' are specific to sera from patients with exophthalmos, and may have a role in the pathogenesis of the ophthalmic complications of Graves's disease. Plasmapheresis is an effective treatment in Goodpasture's syndrome'2 and myasthenia gravis,'3 14 where specific circulating IgGs mediate the basic injury. Hence it seemed appropriate to use plasma exchange in a patient with Graves's disease with progressive exophthalmos and pretibial myxoedema. We report the response of this patient in terms of both the clinical remission observed and sequential changes in serum IgG concentrations and TSI index.
Case report
A 57-year-old Caucasian woman presented in August 1977 with abdominal pain, diarrhoea, anxiety, palpitation, dyspnoea, and ankle swelling. She had pronounced tremor, proximal myopathy, and a diffuse, firm enlargement of the thyroid with a bruit. There was lid-lag but no lid retraction and no exophthalmos. Four years before she had had a left-sided radical mastectomy for carcinoma. Three female cousins of her father had had thyroid disease, and her husband had had recurrent thyrotoxicosis. Both her serum thyroxine (T4) concentration and free thyroxine index (FTI) were raised (T4 199 nmol/l (15 5 tg/1O0 ml); FTI 297"0). She was given 30 mg carbimazole daily, propranolol, and cyclopenthiazide-K but within three weeks developed an irritating exanthematous rash. The drugs were stopped, and in September she was treated with iodine -131 (10 mCi). Metoprolol and cyclopenthiazide-K were added.
In November periorbital oedema with minimal exophthalmos were noted. In December there was limitation of the upward movement of both eyes and pretibial myxoedema had developed. Serum T4 was still raised. Propylthiouracil 300 mg daily was started. By January 1978 the pretibial myxoedema was more pronounced, and local Dermojet injections of triamcinolone (total dose 35 mg) into the lesions were administered. No noticeable improvement occurred. By March the pretibial myxoedema lesions had become hairy, pruritic, and greatly indurated. Onycholysis had appeared. Exophthalmos was severe (exophthalmometry: right 24 mm, left 24 mm). There was no upward movement of the eyes, and pronounced injection and chemosis of both conjunctivae were present. She was clinically and biochemically hypothyroid. Thyroxine (0-1 mg daily) was added to the propylthiouracil treatment.
In view of the relentless progress of the exophthalmos and the risk of corneal injury she was admitted to hospital for plasmapheresis. She was given four sessions of plasma exchange on four successive days (plasmapheresis 1), carried out through a catheter in the femoral vein
